Teleflex appointed Sean M. Salmon to its board on September 8, 2026, adding an executive whose former Medtronic cardiovascular portfolio generated approximately $12.5 billion in fiscal 2025 revenue. He will join the Growth and Operating Committee, which supports strategic transformation, growth opportunities, operational execution and accountability.

Key Highlights

  • Salmon will receive compensation consistent with Teleflex’s non-employee director arrangements.
  • The appointee founded Zamboni Holdings, LLC in December 2025 and provides consulting and advisory services.
  • Teleflex said no arrangements or related-party transactions required disclosure in connection with his appointment.

Teleflex Inc (NYSE: TFX) appointed Sean M. Salmon to its board on September 8, 2026, adding medical-technology Leadership tied to a former Medtronic cardiovascular Business with approximately $12.5 billion in fiscal 2025 revenue. Salmon also joined Teleflex’s Growth and Operating Committee.

Salmon Joins Board and Operating Committee

He previously held executive and senior management roles at Medtronic, including leadership of its cardiovascular, diabetes, coronary and structural heart businesses. Salmon also serves as a director of Adagio Medical Holdings, Inc (NASDAQ: ADGM). and on the Healthcare at Kellogg Advisory Board. Teleflex will compensate Salmon under the arrangements applicable to its non-employee directors, as described in its proxy statement for the 2026 annual meeting. The company said no agreement or understanding governed his selection as a director. It also said no related-party transaction involving Salmon or his Immediate Family required disclosure.

Committee Role Supports Strategic Transformation

The Growth and Operating Committee was established to support management’s execution of Teleflex’s strategic transformation. Its stated areas of focus include operational execution, growth opportunities and accountability across the organization. Salmon most recently led Medtronic’s cardiovascular portfolio, described as a global business with approximately $12.5 billion in fiscal 2025 revenue.